Precision Oncology in Non-Small Cell Lung Cancer: Integrating Molecular Diagnostics, Targeted Therapies, and Resistance Mechanisms
Aleksandra Litkowska, Jan Wojtas, Kaja Nadulska, Grzegorz Kurec, Oliwia Burdan, Paweł Adam Krawczyk · 2026
Read Precision Oncology in Non-Small Cell Lung Cancer: Integrating Molecular Diagnostics, Targeted Therapies, and Resistance Mechanisms by Aleksandra Litkowska, Jan Wojtas, Kaja Nadulska, Grzegorz Kurec, Oliwia Burdan, Paweł Adam Krawczyk (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13606210.txt.
Description
Aleksandra Litkowska and co-authors review how gene-guided care now shapes treatment for the most common form of lung cancer. Their 2026 review looks at tests that find gene changes in a tumor, drugs matched to those changes, and ways tumors learn to resist the drugs.
The team drew on ninety-nine key studies and guides from recent years. Gene tests on tumor samples form the base of this care, and blood tests let doctors track change over time. The review lists the main gene targets now in use, plus a few newer ones. It also groups the ways resistance grows, to help plan what to do when a first drug stops working.
Catalog record
| CREATOR | Aleksandra Litkowska, Jan Wojtas, Kaja Nadulska, Grzegorz Kurec, Oliwia Burdan, Paweł Adam Krawczyk |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |